MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
Amazon
AMZN
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 1.090
- -0.010-0.91%
Close Jan 17 16:00 ET
- 1.090
- 0.0000.00%
Post 19:56 ET
227.43MMarket Cap-1.54P/E (TTM)
1.140High1.075Low4.33MVolume1.100Open1.100Pre Close4.75MTurnover2.12%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High5.80P/B222.40MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM5.91%Amplitude0.291Historical Low1.095Avg Price1Lot Size
About Sangamo Therapeutics Company
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Company Profile
SymbolSGMO
Company NameSangamo Therapeutics
Listing DateApr 6, 2000
Issue Price15.00
Founded1995
CEODr. Alexander Donald Macrae, M.B.,PhD
MarketNASDAQ
Employees405
Fiscal Year Ends12-31
Address501 Canal Boulevard
CityRichmond
ProvinceCalifornia
CountryUnited States of America
Zip Code94084
Phone1-510-970-6000
Websitehttp://www.sangamo.com
Company Executives
- Name
- Position
- Salary
- Dr. Alexander Donald Macrae, M.B.,PhD
- Director, President and Chief Executive Officer
- 2.39M
- Nathalie Dubois-Stringfellow, PhD
- Senior Vice President and Chief Development Officer
- 1.03M
- Prathyusha Duraibabu
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 1.06M
- Amy Pooler, PhD
- Vice President and Head of Research
- --
- Scott B. Willoughby
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Kenneth J. Hillan, Ch.B.,M.B.
- Independent Director
- 71.16K
- Robert F. Carey
- Independent Director
- 80.53K
- Margaret A. Horn, J.D.
- Independent Director
- 71.25K
- James R. Meyers
- Independent Director
- 78.66K
- Courtney Beers
- Independent Director
- 73.24K
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 76.78K
- Dr. John H. Markels, PhD
- Independent Director
- 76.78K
- H. Stewart Parker
- Chairwoman of the Board
- 99.28K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
